Anne Olaug Olsen

  • Associate professor

Publications 2018

Olsen AO (2018)
Human papillomavirus and immunosuppressive drugs in dermatology - a 'neoplastic' combination?
J Eur Acad Dermatol Venereol, 32 (2), 192
DOI 10.1111/jdv.14833, PubMed 29465832

Publications 2017

Danielsen K, Wilsgaard T, Olsen AO, Furberg AS (2017)
Overweight and Weight Gain Predict Psoriasis Development in a Population-based Cohort
Acta Derm Venereol, 97 (3), 332-339
DOI 10.2340/00015555-2530, PubMed 27602427

Unemo M, Salado-Rasmussen K, Hansen M, Olsen AO, Falk M, Golparian D, Aasterød M, Ringlander J, Nilsson CS, Sundqvist M, Schønning K, Moi H, Westh H, Jensen JS (2017)
Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016
Clin Microbiol Infect, 24 (5), 533-539
DOI 10.1016/j.cmi.2017.09.006, PubMed 28923377

Publications 2016

Molin SB, De Blasio BF, Olsen AO (2016)
Is the risk for sexually transmissible infections (STI) lower among women with exclusively female sexual partners compared with women with male partners? A retrospective study based on attendees at a Norwegian STI clinic from 2004 to 2014
Sex Health, 13 (3), 257-64
DOI 10.1071/SH15193, PubMed 27050292

Nilsen E, Aasterød M, Hustad PS, Olsen AO (2016)
Mecillinam against genital Chlamydia trachomatis infection: a small-scale proof-of-concept study shows a low cure rate
J Antimicrob Chemother, 71 (8), 2270-2
DOI 10.1093/jac/dkw134, PubMed 27165786

Publications 2015

Wold C, Sorthe J, Hartgill U, Olsen AO, Moghaddam A, Reinton N (2015)
Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR
J Eur Acad Dermatol Venereol, 29 (8), 1616-20
DOI 10.1111/jdv.12963, PubMed 25622510

Publications 2014

Danielsen K, Wilsgaard T, Olsen AO, Eggen AE, Olsen K, Cassano PA, Furberg AS (2014)
Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences
Br J Dermatol, 172 (2), 419-27
DOI 10.1111/bjd.13288, PubMed 25059341

Melby KK, Olsen AO, Dedi L, Gaustad P, Syversen G, Moi H (2014)
[The development of resistance must be monitored--gonococci as an example]
Tidsskr Nor Laegeforen, 134 (5), 507-8
DOI 10.4045/tidsskr.14.0033, PubMed 24621906

Publications 2013

Danielsen K, Olsen AO, Wilsgaard T, Furberg AS (2013)
Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort
Br J Dermatol, 168 (6), 1303-10
DOI 10.1111/bjd.12230, PubMed 23374051

Reinton N, Moi H, Olsen AO, Zarabyan N, Bjerner J, Tønseth TM, Moghaddam A (2013)
Anatomic distribution of Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium infections in men who have sex with men
Sex Health, 10 (3), 199-203
DOI 10.1071/SH12092, PubMed 23751932

Publications 2012

Gervin K, Vigeland MD, Mattingsdal M, Hammerø M, Nygård H, Olsen AO, Brandt I, Harris JR, Undlien DE, Lyle R (2012)
DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes
PLoS Genet, 8 (1), e1002454
DOI 10.1371/journal.pgen.1002454, PubMed 22291603

Unemo M, Golparian D, Skogen V, Olsen AO, Moi H, Syversen G, Hjelmevoll SO (2012)
Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway
Antimicrob Agents Chemother, 57 (2), 1057-61
DOI 10.1128/AAC.01775-12, PubMed 23183436

Publications 2011

Moi H, Vestrheim DF, Olsen AO (2011)
[Reduce the use of one-dose azithromycin]
Tidsskr Nor Laegeforen, 131 (7), 673-4
DOI 10.4045/tidsskr.10.1224, PubMed 21494300

Publications 2007

Grjibovski AM, Olsen AO, Magnus P, Harris JR (2007)
Psoriasis in Norwegian twins: contribution of genetic and environmental effects
J Eur Acad Dermatol Venereol, 21 (10), 1337-43
DOI 10.1111/j.1468-3083.2007.02268.x, PubMed 17958839

Publications 2005

Olsen AO, Grjibovski A, Magnus P, Tambs K, Harris JR (2005)
Psoriasis in Norway as observed in a population-based Norwegian twin panel
Br J Dermatol, 153 (2), 346-51
DOI 10.1111/j.1365-2133.2005.06613.x, PubMed 16086747

Publications 2003

Kristiansen M, Helland A, Kristensen GB, Olsen AO, Lønning PE, Børresen-Dale AL, Ørstavik KH (2003)
X chromosome inactivation in cervical cancer patients
Cancer Genet Cytogenet, 146 (1), 73-6
DOI 10.1016/s0165-4608(03)00152-3, PubMed 14499700

Publications 1999

Lie AK, Skarsvåg S, Haugen OA, Skjeldestad FE, Olsen AO, Skovlund E, Rønningen KS (1999)
Association between the HLA DQB1*0301 gene and human papillomavirus infection in high-grade cervical intraepithelial neoplasia
Int J Gynecol Pathol, 18 (3), 206-10
DOI 10.1097/00004347-199907000-00003, PubMed 12090587

Publications 1998

Helland A, Langerød A, Johnsen H, Olsen AO, Skovlund E, Børresen-Dale AL (1998)
p53 polymorphism and risk of cervical cancer
Nature, 396 (6711), 530-1; author reply 532
DOI 10.1038/25034, PubMed 9859987

Helland A, Olsen AO, Gjøen K, Akselsen HE, Sauer T, Magnus P, Børresen-Dale AL, Rønningen KS (1998)
An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women
Int J Cancer, 76 (1), 19-24
DOI 10.1002/(sici)1097-0215(19980330)76:1<19::aid-ijc4>;2-0, PubMed 9533756

Olsen AO, Dillner J, Skrondal A, Magnus P (1998)
Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis
Epidemiology, 9 (3), 346-9
DOI 10.1097/00001648-199805000-00022, PubMed 9583429

Olsen AO, Orstavik I, Dillner J, Vestergaard BF, Magnus P (1998)
Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III
APMIS, 106 (3), 417-24
DOI 10.1111/j.1699-0463.1998.tb01366.x, PubMed 9548432

Publications 1997

Anderson TI, Wooster R, Laake K, Collins N, Warren W, Skrede M, Elles R, Tveit KM, Johnston SR, Dowsett M, Olsen AO, Møller P, Stratton MR, Børresen-Dale AL (1997)
Screening for ESR mutations in breast and ovarian cancer patients
Hum Mutat, 9 (6), 531-6
DOI 10.1002/(SICI)1098-1004(1997)9:6<531::AID-HUMU6>3.0.CO;2-4, PubMed 9195227

Gjøen K, Sauer T, Olsen AO, Orstavik I (1997)
Correlation between polymerase chain reaction and cervical cytology for detection of human papillomavirus infection in women with and without dysplasia
APMIS, 105 (1), 71-5
DOI 10.1111/j.1699-0463.1997.tb00542.x, PubMed 9063504

Olsen AO, Dillner J, Gjøen K, Magnus P (1997)
Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA
Genitourin Med, 73 (2), 131-5
DOI 10.1136/sti.73.2.131, PubMed 9215097

Publications 1996

Gjøoen K, Olsen AO, Magnus P, Grinde B, Sauer T, Orstavik I (1996)
Prevalence of human papillomavirus in cervical scrapes, as analyzed by PCR, in a population-based sample of women with and without cervical dysplasia
APMIS, 104 (1), 68-74
DOI 10.1111/j.1699-0463.1996.tb00688.x, PubMed 8645461

Olsen AO, Dillner J, Gjøen K, Sauer T, Orstavik I, Magnus P (1996)
A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix
Int J Cancer, 68 (4), 415-9
DOI 10.1002/(SICI)1097-0215(19961115)68:4<415::AID-IJC2>3.0.CO;2-3, PubMed 8945608

Publications 1995

Olsen AO, Gjøen K, Sauer T, Orstavik I, Naess O, Kierulf K, Sponland G, Magnus P (1995)
Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study
Int J Cancer, 61 (3), 312-5
DOI 10.1002/ijc.2910610306, PubMed 7729940

Page visits: 6737